Cargando…

BRCA2 carriers with male breast cancer show elevated tumour methylation

BACKGROUND: Male breast cancer (MBC) represents a poorly characterised group of tumours, the management of which is largely based on practices established for female breast cancer. However, recent studies demonstrate biological and molecular differences likely to impact on tumour behaviour and there...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deb, Siddhartha, Gorringe, Kylie L., Pang, Jia-Min B., Byrne, David J., Takano, Elena A., Investigators, kConFab, Dobrovic, Alexander, Fox, Stephen B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5594583/ https://www.ncbi.nlm.nih.gov/pubmed/28893223 http://dx.doi.org/10.1186/s12885-017-3632-7

Ejemplares similares

Genotypic and phenotypic analysis of familial male breast cancer shows under representation of the HER2 and basal subtypes in BRCA-associated carcinomas
por: Deb, Siddhartha, et al.
Publicado: (2012)

Prostate screening uptake in Australian BRCA1 and BRCA2 carriers
por: McKinley, Joanne M, et al.
Publicado: (2007)

Use of DNA–Damaging Agents and RNA Pooling to Assess Expression Profiles Associated with BRCA1 and BRCA2 Mutation Status in Familial Breast Cancer Patients
por: Walker, Logan C., et al.
Publicado: (2010)

Quantifying BRCA1 and BRCA2 mRNA Isoform Expression Levels in Single Cells
por: Lattimore, Vanessa L., et al.
Publicado: (2019)

PIK3CA mutations are frequently observed in BRCAX but not BRCA2 -associated male breast cancer
por: Deb, Siddhartha, et al.
Publicado: (2013)

Rapid detection of carriers with BRCA1 and BRCA2 mutations using high resolution melting analysis
por: Takano, Elena A, et al.
Publicado: (2008)

BRCA1 and BRCA2 Missense Variants of High and Low Clinical Significance Influence Lymphoblastoid Cell Line Post-Irradiation Gene Expression
por: Waddell, Nic, et al.
Publicado: (2008)

Identification of BRCA1 missense substitutions that confer partial functional activity: potential moderate risk variants?
por: Lovelock, Paul K, et al.
Publicado: (2007)

LRH-1 expression patterns in breast cancer tissues are associated with tumour aggressiveness
por: Pang, Jia-Min B., et al.
Publicado: (2017)

Male BRCA mutation carriers: clinical characteristics and cancer spectrum
por: Ibrahim, Mohammed, et al.
Publicado: (2018)

Appraisal of the technologies and review of the genomic landscape of ductal carcinoma in situ of the breast
por: Pang, Jia-Min B., et al.
Publicado: (2015)

Comparative microRNA profiling of sporadic and BRCA1 associated basal-like breast cancers
por: Yan, Max, et al.
Publicado: (2015)

BRCA1 promoter methylation in peripheral blood DNA of mutation negative familial breast cancer patients with a BRCA1 tumour phenotype
por: Snell, Cameron, et al.
Publicado: (2008)

A high-throughput protocol for mutation scanning of the BRCA1 and BRCA2 genes
por: Hondow, Heather L, et al.
Publicado: (2011)

Methylation profiling of ductal carcinoma in situand its relationship to histopathological features
por: Pang, Jia-Min B, et al.
Publicado: (2014)

Ductal Carcinoma In Situ Biology, Biomarkers, and Diagnosis
por: Gorringe, Kylie L., et al.
Publicado: (2017)

A multiplex endpoint RT-PCR assay for quality assessment of RNA extracted from formalin-fixed paraffin-embedded tissues
por: Takano, Elena A, et al.
Publicado: (2010)

BRCA1 tumours correlate with a HIF-1α phenotype and have a poor prognosis through modulation of hydroxylase enzyme profile expression
por: Yan, M, et al.
Publicado: (2009)

Frequent somatic loss of BRCA1 in breast tumours from BRCA2 germ-line mutation carriers and vice versa
por: Staff, S, et al.
Publicado: (2001)

Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2
por: Mulligan, Anna Marie, et al.
Publicado: (2011)

No evidence for promoter region methylation of the succinate dehydrogenase and fumarate hydratase tumour suppressor genes in breast cancer
por: Huang, Katie T, et al.
Publicado: (2009)

BRCA1 tumours correlate with a HIF-1α phenotype and have a poor prognosis through modulation of hydroxylase enzyme profile expression
por: Yan, M, et al.
Publicado: (2009)

Motivators of Inappropriate Ovarian Cancer Screening: A Survey of Women and Their Clinicians
por: Macdonald, Courtney, et al.
Publicado: (2020)

Evaluating statistical approaches to define clonal origin of tumours using bulk DNA sequencing: context is everything
por: Kader, Tanjina, et al.
Publicado: (2022)

Other cancers in BRCA1 and BRCA2 mutation carriers: implications for counselling and follow up
por: Ponder, B
Publicado: (2000)

Mutational profiling of familial male breast cancers reveals similarities with luminal A female breast cancer with rare TP53 mutations
por: Deb, S, et al.
Publicado: (2014)

Analysis of RAD51D in Ovarian Cancer Patients and Families with a History of Ovarian or Breast Cancer
por: Thompson, Ella R., et al.
Publicado: (2013)

Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
por: Metcalfe, K, et al.
Publicado: (2011)

Comprehensive Assessment of BARD1 Messenger Ribonucleic Acid Splicing With Implications for Variant Classification
por: Walker, Logan C., et al.
Publicado: (2019)

BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers
por: Maxwell, Kara N., et al.
Publicado: (2017)

Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2
por: Silvestri, Valentina, et al.
Publicado: (2016)

Selenium and the risk of cancer in BRCA1 carriers
por: Lubinski, J, et al.
Publicado: (2011)

Analysis of chromosomal radiosensitivity of healthy BRCA2 mutation carriers and non-carriers in BRCA families with the G2 micronucleus assay
por: Baert, Annelot, et al.
Publicado: (2017)

Management of the asymptomatic BRCA mutation carrier
por: Teller, Paige, et al.
Publicado: (2010)

Cancer risks among BRCA1 and BRCA2 mutation carriers
por: Levy-Lahad, E, et al.
Publicado: (2007)

The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers
por: Iqbal, J, et al.
Publicado: (2012)

Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer
por: Warner, Ellen
Publicado: (2018)

Gastric Cancer Risk and Pathogenesis in BRCA1 and BRCA2 Carriers
por: Buckley, Kole H., et al.
Publicado: (2022)

Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype
por: Mitra, A, et al.
Publicado: (2008)

A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers
por: Kadouri, L, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_u32dji769aqv290ura4t6fmqf3